The U.S. Food and Drug Administration today approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27 through 45 years.
About: HNC Support
Recent Posts by HNC Support
Join us February 3rd for the HNC Support Group Meeting with two special guest speakers; Lynn Hasel - RYT500 & Certified Ayurveda Practitioner and Dennis R. Maceri, MD. A skilled and compassionate surgeon specializing in head, neck and endocrine surgery, with over four decades of experience.
Recent Comments by HNC Support
No comments by HNC Support yet.